Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Combined blockade of 5-HT1A and 5-HT1B receptors potentiates fluoxetine activity

May 7, 1997

Neuromyalgic response to rhNGF described

May 6, 1997

Rhone-Poulenc Rorer licenses Granocyte for additional countries

May 6, 1997

AGM-1470 may have potential for controlling fertility

May 6, 1997

Squalene synthase inhibitors reported by Takeda

May 6, 1997

Pfizer's CP-148623 lowers serum cholesterol in humans

May 6, 1997

BTS-67582 in diabetes

May 5, 1997

Hypolipidemic triterpenes claimed by Leo

May 5, 1997

Somatogen initiates phase II Optro trial for new indication

May 2, 1997

Ethical initiates U.S. pivotal trials of HRT combination patch

May 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...